Tempest Therapeutics (TPST) Short-term Investments (2012 - 2023)
Tempest Therapeutics (TPST) posted Short-term Investments of $450000.0 for Q1 2023, little changed sequentially from $450000.0 in Q4 2022, and down 97.0% YoY from $15.0 million in Q1 2022.
Tempest Therapeutics (TPST) Short-term Investments (2012 - 2023) Analysis & Trends
Tempest Therapeutics has reported Short-term Investments for 12 years, with the latest figure at $450000.0 in Q1 2023.
- Quarterly Short-term Investments fell 97.0% year-over-year to $450000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $450000.0 (down 97.0% YoY) and the FY2022 annual result came in at $450000.0, down 97.0% from the prior year.
- Short-term Investments held at $450000.0 in Q1 2023 per TPST's latest filing, from $450000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $15.2 million in Q3 2022 and troughed at $45000.0 in Q1 2019.
- A 5-year average of $5.3 million and a median of $705000.0 in 2020 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2019 and 2022: Short-term Investments tumbled 99.88% in 2019, then jumped 33677.78% in 2022.
- Over 5 years, Short-term Investments stood at $1.0 million in 2019, then sank by 31.82% to $705000.0 in 2020, then surged by 2027.66% to $15.0 million in 2021, then tumbled by 97.0% to $450000.0 in 2022, then changed by 0.0% to $450000.0 in 2023.
- According to Business Quant data, Short-term Investments over the past three periods registered $450000.0, $450000.0, and $15.2 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 450,000.00 |
| Sep 30, 2022 | 15.20 Mn |
| Jun 30, 2022 | 15.00 Mn |
| Mar 31, 2022 | 15.00 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 45,000.00 |
| Jun 30, 2021 | 45,000.00 |
| Mar 31, 2021 | 15.00 Mn |
| Jun 30, 2020 | 705,000.00 |
| Mar 31, 2020 | 870,000.00 |
| Dec 31, 2019 | 1.03 Mn |
| Sep 30, 2019 | 703,000.00 |
| Jun 30, 2019 | 699,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | 789,000.00 |
| Jun 30, 2018 | 29.03 Mn |
| Mar 31, 2018 | 38.58 Mn |
| Dec 31, 2017 | 45,000.00 |